PRVA Analyst Ratings
Privia Health Group, Inc. (PRVA) operates in the Healthcare sector, specifically the Medical - Healthcare Information Services industry, with a market capitalization near $2.85B, listed on NASDAQ, employing roughly 1,140 people, carrying a beta of 0.97 to the broader market. Privia Health Group, Inc. Led by Parth Mehrotra, public since 2021-04-28.
Consensus: Mixed from 0 analysts.
Price Targets
- Average Target
- $31.20
- High
- $36.00
- Low
- $26.00
Recent Upgrades & Downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 8, 2026 | Canaccord Genuity | maintain | Buy | Buy |
| Apr 8, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Mar 25, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Mar 3, 2026 | Citigroup | maintain | Buy | Buy |
| Mar 2, 2026 | Truist Securities | maintain | Buy | Buy |
How to Read PRVA Analyst Coverage
Sell-side equity analysts publish three primary outputs: ratings (Strong Buy / Buy / Hold / Sell / Strong Sell, or firm-specific equivalents), price targets, and EPS / revenue estimate revisions. Rating consensus moves slowly relative to price; it reflects 12-month directional conviction rather than near-term momentum. Price targets are more responsive but typically drift behind realized price during sharp moves. The most actionable signal for options traders is a cluster of ratings actions across multiple firms within a short window, which compresses or expands implied volatility on a horizon of days to weeks and shifts the put-call skew toward the directional consensus. The recent-actions table above shows the five most recent firm-level changes; longer histories live behind aggregator sources.
For event-driven options sizing, pair the consensus rating and target distribution with the implied-volatility surface and dealer-positioning view. Aggressive target hikes from multiple firms tend to tighten put skew (downside protection becomes relatively cheaper); aggressive cuts widen put skew. The size of the IV response in the hours after a rating change is visible on the per-ticker volatility skew page and the gamma-exposure page, both of which show how dealer hedging propagates the analyst-driven flow into the listed options chain.
Learn how analyst ratings is reported and how to read the data →
Frequently asked PRVA analyst ratings questions
- What is the PRVA consensus price target?
- As of the latest aggregator update, Privia Health Group, Inc. (PRVA) carries a consensus 12-month price target of $31.20. Target ranges run from a low of $26.00 to a high of $36.00. The target is the average of the price targets published by sell-side equity analysts covering the name.
- What is the analyst rating consensus on PRVA?
- Analyst rating consensus is not currently available for PRVA.
- What recent ratings actions has PRVA seen?
- The five most recent ratings actions on PRVA appear on the page above. Sell-side rating changes are watched for two reasons: an upgrade or downgrade with a meaningful target revision moves the consensus and can trigger short-term positioning shifts, and the firm-level rating cluster (multiple firms moving in the same direction within a short window) is a clearer signal than any single action. Options markets often price the implied-vol response within minutes of the announcement.
- How do analyst targets affect PRVA options pricing?
- Analyst target revisions tend to be priced in by the lit options market within minutes of publication, but persistent target drift over weeks does correlate with implied-volatility movement. Aggressive target hikes from multiple firms inside a single quarter tighten put skew (downside protection becomes cheaper relative to upside speculation); aggressive cuts widen put skew. The most actionable read is the implied-vol response in the hours after a target change, which is visible on the per-ticker volatility skew page.